TipRanks
Advertisement
Advertisement
Arcus Buy Rating Reiterated as Casdatifan Data Catalysts Approach; Price Target Maintained at $46
PremiumRatingsArcus Buy Rating Reiterated as Casdatifan Data Catalysts Approach; Price Target Maintained at $46
22d ago
Arcus Biosciences Nears Key Data Milestone in Pancreatic Cancer Trial
Premium
Company Announcements
Arcus Biosciences Nears Key Data Milestone in Pancreatic Cancer Trial
26d ago
Arcus Biosciences price target raised to $40 from $35 at Truist
Premium
The Fly
Arcus Biosciences price target raised to $40 from $35 at Truist
27d ago
Arcus Biosciences price target raised to $42 from $34 at Goldman Sachs
PremiumThe FlyArcus Biosciences price target raised to $42 from $34 at Goldman Sachs
2M ago
Salim Syed Initiates Buy on Arcus, Citing Casdatifan’s Foundational RCC Potential and Diversified Late-Stage Pipeline Ahead of 2026 Inflection Data
Premium
Ratings
Salim Syed Initiates Buy on Arcus, Citing Casdatifan’s Foundational RCC Potential and Diversified Late-Stage Pipeline Ahead of 2026 Inflection Data
2M ago
Arcus Biosciences price target raised to $43 from $41 at Wedbush
Premium
The Fly
Arcus Biosciences price target raised to $43 from $41 at Wedbush
2M ago
Buy Rating Reaffirmed on Arcus Biosciences as New RCC Partnerships Strengthen Multi-Line Development Strategy
PremiumRatingsBuy Rating Reaffirmed on Arcus Biosciences as New RCC Partnerships Strengthen Multi-Line Development Strategy
2M ago
Arcus, Summit enter into clinical trial collaboration over kidney cancer
Premium
The Fly
Arcus, Summit enter into clinical trial collaboration over kidney cancer
2M ago
Arcus Biosciences announces clinical supply pact with AVEO Oncology
Premium
The Fly
Arcus Biosciences announces clinical supply pact with AVEO Oncology
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―